DOW JONES NEWSWIRES -- Health-care giant Johnson & Johnson (JNJ) reported a 29% increase in first-quarter profit on the settlement of a patent dispute, but said the recently enacted U.S. health overhaul would take a bite out of financial results this year and next.
